146 related articles for article (PubMed ID: 34142230)
1. Incidence, predictive factors and oncological outcomes of incidental prostate cancer after endoscopic enucleation of the prostate: a systematic review and meta-analysis.
Cheng BK; Castellani D; Chan IS; Baker A; Gauhar V; Wroclawski ML; Santamaria HT; Tanidir Y; Enikeev D; Chan VW; Ng CF; Herrmann T; Teoh JY
World J Urol; 2022 Jan; 40(1):87-101. PubMed ID: 34142230
[TBL] [Abstract][Full Text] [Related]
2. Is there a PSA cut-off value indicating incidental prostate cancer in patients undergoing surgery for benign prostatic hyperplasia?
Tonyali S; Ceylan C; Aglamis E; Dogan S; Tastemur S; Karaaslan M
Arch Ital Urol Androl; 2021 Mar; 93(1):31-34. PubMed ID: 33754606
[TBL] [Abstract][Full Text] [Related]
3. Is the systematic histological analysis of benign prostatic hyperplasia surgical specimen always necessary?
Coman R; Anract J; Pinar U; Sibony M; Peyromaure M; Delongchamps B
Int Urol Nephrol; 2022 Jul; 54(7):1485-1489. PubMed ID: 35536389
[TBL] [Abstract][Full Text] [Related]
4. "Finding the needle in a haystack": oncologic evaluation of patients treated for LUTS with holmium laser enucleation of the prostate (HoLEP) versus transurethral resection of the prostate (TURP).
Herlemann A; Wegner K; Roosen A; Buchner A; Weinhold P; Bachmann A; Stief CG; Gratzke C; Magistro G
World J Urol; 2017 Nov; 35(11):1777-1782. PubMed ID: 28516315
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of the preoperative PSA level for predicting clinically significant incidental transitional zone-prostate cancer before endoscopic enucleation of very large adenoma.
Misraï V; Pasquie M; Bordier B; Guillotreau J; Gryn A; Palasse J; Bruguière E; Pradere B; Rouprêt M; Zorn KC
World J Urol; 2020 Apr; 38(4):993-1000. PubMed ID: 31139906
[TBL] [Abstract][Full Text] [Related]
6. Incidental prostate cancer at holmium laser enucleation of prostate.
Shvero A; Teplitsky S; Klonicke E; Das AK
Can J Urol; 2021 Dec; 28(6):10900-10906. PubMed ID: 34895394
[TBL] [Abstract][Full Text] [Related]
7. HoLEP provides a higher prostate cancer detection rate compared to bipolar TURP: a matched-pair analysis.
Rosenhammer B; Lausenmeyer EM; Mayr R; Burger M; Eichelberg C
World J Urol; 2018 Dec; 36(12):2035-2041. PubMed ID: 29858700
[TBL] [Abstract][Full Text] [Related]
8. Incidental prostate cancer after holmium laser enucleation of the prostate: incidence and predictive factors for clinical progression.
Klein C; Marquette T; Capon G; Yacoub M; Alezra E; Bernhard JC; Bladou F; Robert G
Int J Clin Oncol; 2022 Jun; 27(6):1077-1083. PubMed ID: 35333999
[TBL] [Abstract][Full Text] [Related]
9. Does mechanical morcellation of large glands compromise incidental prostate cancer detection on specimen analysis? A pathological comparison with open simple prostatectomy.
Misraï V; Kerever S; Pasquie M; Bordier B; Guillotreau J; Palasse J; Guillotreau V; Rijo E; Vincendeau S; Huet R; Mathieu R; Peyronnet B; Rioux-Leclercq N; Compérat EM
World J Urol; 2019 Jul; 37(7):1315-1320. PubMed ID: 30350017
[TBL] [Abstract][Full Text] [Related]
10. Bipolar endoscopic enucleation versus bipolar transurethral resection of the prostate: an ESUT systematic review and cumulative analysis.
Arcaniolo D; Manfredi C; Veccia A; Herrmann TRW; Lima E; Mirone V; Fusco F; Fiori C; Antonelli A; Rassweiler J; Liatsikos E; Porpiglia F; De Sio M; Autorino R;
World J Urol; 2020 May; 38(5):1177-1186. PubMed ID: 31346761
[TBL] [Abstract][Full Text] [Related]
11. "In-bore" MRI prostate biopsy is a safe preoperative clinical tool to exclude significant prostate cancer in symptomatic patients with benign prostatic obstruction before transurethral laser enucleation.
Porreca A; D'Agostino D; Vigo M; Corsi P; Romagnoli D; Del Rosso A; Schiavina R; Brunocilla E; Artibani W; Giampaoli M
Arch Ital Urol Androl; 2020 Jan; 91(4):224-229. PubMed ID: 31937084
[TBL] [Abstract][Full Text] [Related]
12. Changes in serum PSA after endoscopic enucleation of the prostate are predictive for the future diagnosis of prostate cancer.
Lambert E; Goossens M; Palagonia E; Vollemaere J; Mazzone E; Dell'Oglio P; Pauwels E; De Groote R; D'Hondt F; Mottrie A; De Naeyer G; Schatteman P
World J Urol; 2021 Jul; 39(7):2621-2626. PubMed ID: 32997261
[TBL] [Abstract][Full Text] [Related]
13. The significance of a high preoperative PSA level for the detection of incidental prostate cancer in LUTS patients with large prostates.
Magistro G; Keller P; Westhofen T; Schott M; Tamalunas A; Weinhold P; Stief CG
World J Urol; 2021 May; 39(5):1481-1487. PubMed ID: 32588205
[TBL] [Abstract][Full Text] [Related]
14. Preoperative clinical factors for diagnosis of incidental prostate cancer in the era of tissue-ablative surgery for benign prostatic hyperplasia: a korean multi-center review.
Yoo C; Oh CY; Kim SJ; Kim SI; Kim YS; Park JY; Seong do H; Song YS; Yang WJ; Chung HC; Cho IR; Cho SY; Cheon SH; Hong S; Cho JS
Korean J Urol; 2012 Jun; 53(6):391-5. PubMed ID: 22741046
[TBL] [Abstract][Full Text] [Related]
15. Favorable long-term oncological and urinary outcomes of incidental prostate cancer following holmium laser enucleation of the prostate.
Tominaga Y; Sadahira T; Mitsui Y; Maruyama Y; Tanimoto R; Wada K; Munemasa S; Kusaka N; Nishiyama Y; Kurashige T; Nasu Y; Hayata S
Mol Clin Oncol; 2019 Jun; 10(6):605-609. PubMed ID: 31031975
[TBL] [Abstract][Full Text] [Related]
16. Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasia.
Helfand BT; Anderson CB; Fought A; Kim DY; Vyas A; McVary KT
Urology; 2009 Jul; 74(1):177-83. PubMed ID: 19428074
[TBL] [Abstract][Full Text] [Related]
17. Serum early prostate cancer antigen (EPCA) as a significant predictor of incidental prostate cancer in patients undergoing transurethral resection of the prostate for benign prostatic hyperplasia.
Zhao Z; Zeng G; Zhong W
Prostate; 2010 Dec; 70(16):1788-98. PubMed ID: 20583137
[TBL] [Abstract][Full Text] [Related]
18. Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - a medium term, prospective, randomized comparison.
Geavlete B; Stanescu F; Iacoboaie C; Geavlete P
BJU Int; 2013 May; 111(5):793-803. PubMed ID: 23469933
[TBL] [Abstract][Full Text] [Related]
19. Significance of prostate-specific antigen-related factors in incidental prostate cancer treated by holmium laser enucleation of the prostate.
Otsubo S; Yokomizo A; Mochida O; Shiota M; Tatsugami K; Inokuchi J; Naito S
World J Urol; 2015 Mar; 33(3):329-33. PubMed ID: 24804843
[TBL] [Abstract][Full Text] [Related]
20. Incidental prostate cancer after transurethral resection of the prostate: analysis of incidence and risk factors in 458 patients.
Porcaro AB; Tafuri A; Inverardi D; Amigoni N; Sebben M; Pirozzi M; Processali T; Rizzetto R; Shakir A; Cerrato C; Tiso L; Panunzio A; DE Michele M; Brunelli M; Siracusano S; Artibani W
Minerva Urol Nephrol; 2021 Aug; 73(4):471-480. PubMed ID: 32003204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
